The results showed that TPM1 and TPM2 were significantly upregulated in bladder cancer, with log2 fold-change values of +1.76 and +1.71, respectively, and adjusted p-values < 1E-13, indicating robust statistical support. The gene discussed is TPM2; the disease is urinary bladder cancer.